ReviewTrauma surgery & acute care open2026
Fueling recovery: evidence-based ICU nutrition and immunonutrition strategies in 2026.
Review in Trauma surgery & acute care open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- TCCACS and MDR 2026 introduction.Trauma surgery & acute care open · 2026Article
- Preoperative nutrition in colorectal cancer surgery: mini review.Frontiers in nutrition · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Our understanding of the metabolic response to critical illness continues to evolve and delivery of nutrition therapy in the intensive care unit (ICU) has become more nuanced. Both underfeeding and overfeeding have recognized harms, and it is often challenging to provide the right dose at the right time by the right route to the right patient. The historic 'ebb and flow' model of critical illness metabolism has been replaced by a modern model describing early and late acute phase, chronic phase and convalescent phase. Macronutrient delivery should be tailored to not only the patient but also the phase of critical illness. In the absence of contraindications to enteral nutrition (EN), trophic rate EN should begin when acute resuscitation is complete, typically within 48 hours of ICU admission. During the first week or early acute phase of critical illness, energy delivery should be limited to no more than 70%-80% of 'full' nutrition because of the unavoidable presence of endogenous glucose production. Similarly, protein delivery should be limited to ≤1.2 g/kg/day. After the early acute phase, both energy and protein prescription should increase to 100% 'full' nutrition and 1.2-2.0 g/kg/day. In the chronic convalescent and post-ICU phase, even higher energy and protein prescriptions may be necessary to regain lost muscle mass and function. Early physical therapy or neuromuscular stimulation is safe, feasible and likely beneficial. Although intravenous glutamine and arginine are no longer recommended, there may be a role for intravenous fish oil and enteral glutamine (only for burns >20% Total Body Surface Area (TBSA)).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.